Sargent Investment Group LLC Invests $209,000 in Colgate-Palmolive (NYSE:CL)

Sargent Investment Group LLC purchased a new position in Colgate-Palmolive (NYSE:CL) during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund purchased 2,403 shares of the company’s stock, valued at approximately $209,000.

A number of other institutional investors have also recently made changes to their positions in the company. E. Ohman J or Asset Management AB boosted its stake in shares of Colgate-Palmolive by 1,108.5% in the fourth quarter. E. Ohman J or Asset Management AB now owns 386,730 shares of the company’s stock worth $35,158,000 after acquiring an additional 354,730 shares during the last quarter. Welch Group LLC lifted its position in Colgate-Palmolive by 1.5% during the fourth quarter. Welch Group LLC now owns 631,619 shares of the company’s stock worth $57,345,000 after buying an additional 9,137 shares in the last quarter. Commonwealth Financial Services LLC lifted its position in Colgate-Palmolive by 4.5% during the fourth quarter. Commonwealth Financial Services LLC now owns 2,716 shares of the company’s stock worth $247,000 after buying an additional 118 shares in the last quarter. Calamos Wealth Management LLC lifted its position in Colgate-Palmolive by 1.7% during the fourth quarter. Calamos Wealth Management LLC now owns 16,253 shares of the company’s stock worth $1,478,000 after buying an additional 277 shares in the last quarter. Finally, Calamos Advisors LLC lifted its position in Colgate-Palmolive by 0.3% during the fourth quarter. Calamos Advisors LLC now owns 302,648 shares of the company’s stock worth $27,514,000 after buying an additional 805 shares in the last quarter. 80.41% of the stock is owned by institutional investors and hedge funds.

Colgate-Palmolive Trading Up 0.2 %

Shares of NYSE CL opened at $86.66 on Thursday. Colgate-Palmolive has a twelve month low of $82.68 and a twelve month high of $109.30. The company has a current ratio of 0.41, a quick ratio of 0.26 and a debt-to-equity ratio of 9.46. The stock has a fifty day simple moving average of $90.98 and a 200-day simple moving average of $96.99. The stock has a market capitalization of $70.80 billion, a PE ratio of 24.62, a PEG ratio of 3.61 and a beta of 0.44.

Colgate-Palmolive (NYSE:CL) last issued its quarterly earnings results on Friday, January 31st. The company reported $0.91 earnings per share for the quarter, topping the consensus estimate of $0.90 by $0.01. Colgate-Palmolive had a return on equity of 477.77% and a net margin of 14.38%. During the same quarter in the prior year, the business posted $0.87 EPS. On average, equities analysts forecast that Colgate-Palmolive will post 3.74 earnings per share for the current year.

Colgate-Palmolive Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Shareholders of record on Tuesday, January 21st will be issued a dividend of $0.50 per share. The ex-dividend date of this dividend is Tuesday, January 21st. This represents a $2.00 annualized dividend and a yield of 2.31%. Colgate-Palmolive’s dividend payout ratio (DPR) is 56.82%.

Wall Street Analysts Forecast Growth

A number of brokerages recently commented on CL. TD Cowen reduced their price objective on Colgate-Palmolive from $110.00 to $100.00 and set a “buy” rating on the stock in a research report on Wednesday, January 8th. UBS Group reduced their price objective on Colgate-Palmolive from $104.00 to $100.00 and set a “buy” rating on the stock in a research report on Monday. Piper Sandler reduced their price objective on Colgate-Palmolive from $121.00 to $112.00 and set an “overweight” rating on the stock in a research report on Monday, January 6th. Wells Fargo & Company reduced their price objective on Colgate-Palmolive from $92.00 to $83.00 and set an “underweight” rating on the stock in a research report on Tuesday, January 7th. Finally, Royal Bank of Canada restated a “sector perform” rating and issued a $101.00 target price on shares of Colgate-Palmolive in a research report on Wednesday, January 29th. One research analyst has rated the stock with a sell rating, ten have assigned a hold rating and twelve have issued a buy rating to the company’s stock. Based on data from MarketBeat, Colgate-Palmolive currently has an average rating of “Hold” and an average target price of $101.16.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.